"Phenobarbital Resurgence: A Renaissance in Modern Alcohol Withdrawal T" by Mohmed Imran Gora, Chee Yao Lim et al.
 

Phenobarbital Resurgence: A Renaissance in Modern Alcohol Withdrawal Treatment

Document Type

Article

Publication Date

10-2024

Publication Title

Chest Journal

Abstract

Alcohol withdrawal syndrome poses a significant burden on healthcare systems, impacting approximately 9% of the US population and resulting in substantial healthcare utilization costs, estimated at $30 billion. Within this context, Lincoln Hospital, a safety-net institution serving a socioeconomically disadvantaged population, contends with heightened rates of alcohol/substance use disorders and associated complications, exacerbating the strain on healthcare resources. This study aims to evaluate the efficacy of phenobarbital in reducing Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) scores, impacting hospitalization rates, and assessing intensive care unit (ICU) utilization compared to conventional benzodiazepine therapy among patients admitted for alcohol withdrawal.

Volume

166

Issue

4

First Page

A2721

Last Page

A2722

DOI

10.1016/j.chest.2024.06.1650

This document is currently not available here.

Share

COinS